柳红芳基于"平治于权衡,去宛陈莝"辨证论治糖尿病肾病经验

扫码查看

原文链接

NETL
NSTL
万方数据

中文摘要：糖尿病肾病是常见的慢性疾病之一，临床目前缺乏有效的针对性治疗手段。柳红芳教授中西医融会贯通，根据数十年临床经验，将"平治于权衡，去宛陈莝"理论应用于糖尿病肾病的治疗，以病统证审查病机，治疗全过程紧扣该病"精损络痹"的核心病机。临证运用熟地黄-黄芪-山茱萸角药填精补肾、平衡阴阳以平治于权衡，辨证审因使用黄连-金银花-鬼箭羽、川芎-鸡血藤-水蛭、佩兰-茯苓-泽泻、土茯苓-萆薢-大黄等角药多层次多途径通络除痹以去宛陈莝，达到全程延缓疾病进展、缓解患者临床症状的目的。

外文标题：Liu Hongfang's experience in the syndrome differentiation and treatment of diabetic nephropathy based on"treating in balanced way and removing from wanchen"

外文摘要：Diabetic nephropathy is one of the common chronic diseases,and there is no effective targeted treatment in clinic.Professor Liu Hongfang integrates traditional Chinese medicine and western medicine,and applies the theory of"treating in balanced way and removing from wanchen"to treating diabetic nephropathy based on decades of clinical experience.She examines pathogenesis of the disease based on syndromes,and closely follows the core pathogenesis of"kidney damage and collateral obstruction"throughout entire treatment process.In clinical practice,the use of triplet herbs of Rehmanniae Radix Praeparata-Astragali Radix-Cornifructus to nourish kidney and balance yin and yang can be used to treating in balanced way.The use of triplet herbs of Coptidis Rhizoma-Lonicerae Japonicae Flos-Euonymus Alatus,Chuanxiong Rhizoma-Spatholobi Caulis-Hirudo,Eupatorii Herba-Poria-Alismatis Rhizoma,Smilacis Glabrae Rhizoma-Rhizoma Dioscoreae Hypoglaucae-Rhei Radix Et Rhizoma can be used to remove obstruction of meridians and removing from wanchen through multiple levels and multiple pathways,so as to delay progression of the disease and alleviate clinical symptoms of patients.

外文关键词：

Treating in balanced way,removing from wanchenDiabetic nephropathyTriplet herbsSyndrome differentiation based on diseaseLiu HongfangExperience of famous doctor

作者：

梅洁、徐哲宇、于欣卉、董昭熙、蔡丰翼、臧欣悦、柳红芳

展开 >

作者单位：

北京中医药大学东直门医院,北京 100700

关键词：

平治于权衡,去宛陈莝糖尿病肾病角药以病统证柳红芳名医经验

基金：

首都卫生发展科研专项项目北京中医药大学东直门医院临床研究和成果转化能力提升试点项目北京中医药大学基本科研业务费揭榜挂帅项目

项目编号：

首发2024-1-4192DZMG-XZYY-230052023-JYB-JBZD-023

出版年：

2024

DOI：

10.20047/j.issn1673-7210.2024.21.23

中国医药导报

中国医学科学院

中国医药导报

CSTPCD

影响因子：1.759

ISSN：1673-7210

年,卷(期)：2024.21(21)